On June 8, 2010 if you eat at Noodles and Company in Glenview (1851 Tower Drive, Glenview, IL) on June 8th and mention the Leukemia and Lymphoma Society a portion of the sales will go to the Society.
An estimated 912,938 people in the United States are living with,
or are in remission from, leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma or myeloma.
Every four minutes, someone new is diagnosed with blood cancer.
Every 10 minutes, someone dies.-
The Leukemia and Lymphoma Society (LLS) has invested more than $680 million in research, approximately $69 million in fiscal year 2009 alone. Programs like the Specialized Center of Research (SCOR), which brings together teams of scientists from different disciplines and our Translational Research Program, which funds research with a high probability of producing innovative patient treatments in an accelerated time frame, have directly contributed to many breakthrough cancer treatments.
Research funded by LLS has led or contributed to advances such as chemotherapy, bone marrow and stem cell transplantation and new, targeted oral therapies such as Gleevec®